一项针对非酒精性脂肪性肝病患者的微生物组网络对运动和饮食干预反应的随机对照试验。

A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease.

机构信息

Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.

Exercise, Health and Technology Center, Faculty of Physical Education, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Nat Commun. 2022 May 10;13(1):2555. doi: 10.1038/s41467-022-29968-0.

Abstract

Exercise and diet are treatments for nonalcoholic fatty liver disease (NAFLD) and prediabetes, however, how exercise and diet interventions impact gut microbiota in patients is incompletely understood. We previously reported a 8.6-month, four-arm (Aerobic exercise, n = 29; Diet, n = 28; Aerobic exercise + Diet, n = 29; No intervention, n = 29) randomized, singe blinded (for researchers), and controlled intervention in patients with NAFLD and prediabetes to assess the effect of interventions on the primary outcomes of liver fat content and glucose metabolism. Here we report the third primary outcome of the trial-gut microbiota composition-in participants who completed the trial (22 in Aerobic exercise, 22 in Diet, 23 in Aerobic exercise + Diet, 18 in No Intervention). We show that combined aerobic exercise and diet intervention are associated with diversified and stabilized keystone taxa, while exercise and diet interventions alone increase network connectivity and robustness between taxa. No adverse effects were observed with the interventions. In addition, in exploratory ad-hoc analyses we find that not all subjects responded to the intervention in a similar manner, when using differentially altered gut microbe amplicon sequence variants abundance to classify the responders and low/non-responders. A personalized gut microbial network at baseline could predict the individual responses in liver fat to exercise intervention. Our findings suggest an avenue for developing personalized intervention strategies for treatment of NAFLD based on host-gut microbiome ecosystem interactions, however, future studies with large sample size are needed to validate these discoveries. The Trial Registration Number is ISRCTN 42622771.

摘要

运动和饮食是治疗非酒精性脂肪性肝病(NAFLD)和糖尿病前期的方法,然而,运动和饮食干预如何影响患者的肠道微生物群尚不完全清楚。我们之前报道了一项为期 8.6 个月的、四臂(有氧运动,n=29;饮食,n=28;有氧运动+饮食,n=29;无干预,n=29)随机、单盲(对研究人员)、对照干预试验,以评估干预措施对非酒精性脂肪性肝病和糖尿病前期患者的主要结果肝脂肪含量和葡萄糖代谢的影响。在这里,我们报告了该试验的第三个主要结果——试验参与者的肠道微生物组成(有氧运动组 22 人、饮食组 22 人、有氧运动+饮食组 23 人、无干预组 18 人)。我们表明,联合有氧运动和饮食干预与多样化和稳定的关键分类群有关,而单独的运动和饮食干预会增加分类群之间的网络连接性和稳健性。干预没有观察到不良反应。此外,在探索性特设分析中,我们发现,并非所有受试者都以类似的方式对干预做出反应,当使用差异改变的肠道微生物扩增子序列变异丰度来对响应者和低/非响应者进行分类时。基线时的个性化肠道微生物网络可以预测个体对运动干预的肝脂肪反应。我们的研究结果表明,基于宿主-肠道微生物群落生态系统相互作用,为治疗非酒精性脂肪性肝病开发个性化干预策略提供了一种途径,但需要更大样本量的未来研究来验证这些发现。试验注册号为 ISRCTN42622771。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a91/9091228/993645fce0ed/41467_2022_29968_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索